Shandong Huazhilin Pharmaceutical Technology Co., Ltd.

Shandong Hagilin Pharmaceutical Technology Co., Ltd. was established in 2009. is a member unit of the National High and New Technology Enterprise, China Pharmaceutical Packaging Association, China Vaccine Association, and Shandong Pharmaceutical Industry Association. "Hagilin" trademark was rated as a well-known trademark in Shandong Province. The company was listed in Qilu Equity Trading Center and was rated as the company with "the most investment value". It was awarded honorary titles such as "Specializing in Special Innovation" in Shandong Province and "Gazelle Enterprise" in Zibo City. Currently, it has over 30 national patents. The company focuses on the research, development, production, and sales of high-end pharmaceutical packaging, with its customer base mainly being among the top 100 pharmaceutical companies and biopharmaceutical companies. Products include: pharmaceutical polyethylene bags, pharmaceutical polyethylene sterile bags, powder transfer bags, pharmaceutical breathing bags, reaction bags, and other biopharmaceutical one-time customization systems (SUS), high barrier preparation packaging products. Shandong threewin Pharmaceutical Technology Co., Ltd. is a holding subsidiary of Hagilin, with the brand of "threewin". It mainly engages in silicone rubber products such as medical silicone transmission tubes, high-precision and ultra-durable peristaltic pump tubes, and TPE thermoplastic tubes. The company organizes the production of drug packaging materials in strict accordance with the "Drug GMP", and has passed multiple quality management system certifications such as the EU GMP, ISO9001 system, and excellent performance management system. Hagilin has always adhered to the core values of "focusing on quality, continuous innovation, and serving customers", positioned itself as a "pharmaceutical protection expert", and is determined to provide safe pharmaceutical packaging and whole-process solutions for pharmaceutical companies, contributing to the development of the world's pharmaceutical industry.